Yongcan Xu

Huzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Targeted therapy in thyroid cancer: molecular alterations and clinical management.

Targeted therapy in thyroid cancer: molecular alterations and clinical management.

Journal: Frontiers in endocrinology

Published: February 13, 2026

B7-H3 and ICAM-1 are potentially therapeutic targets for thyroid carcinoma.

B7-H3 and ICAM-1 are potentially therapeutic targets for thyroid carcinoma.

Journal: Diagnostic pathology

Published: January 06, 2024

Correction: Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer.

Correction: Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 06, 2023

LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis.

LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis.

Journal: Journal of chemotherapy (Florence, Italy)

Published: December 22, 2022

Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer.

Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer.

Journal: BMC cancer

Published: March 30, 2022

LncRNA RP11-138J23.1 Contributes to Gastric Cancer Progression by Interacting With RNA-Binding Protein HuR.

LncRNA RP11-138J23.1 Contributes to Gastric Cancer Progression by Interacting With RNA-Binding Protein HuR.

Journal: Frontiers in oncology

Published: January 04, 2022

Long noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN/STAT1 signaling pathway.

Long noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN/STAT1 signaling pathway.

Journal: Pathology, research and practice

Published: October 21, 2021

The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism.

The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 07, 2020

Absent Cortical Venous Filling Is Associated with Aggravated Brain Edema in Acute Ischemic Stroke.

Absent Cortical Venous Filling Is Associated with Aggravated Brain Edema in Acute Ischemic Stroke.

Journal: AJNR. American journal of neuroradiology

Published: July 17, 2020

circRNAs and Exosomes: A Mysterious Frontier for Human Cancer.

circRNAs and Exosomes: A Mysterious Frontier for Human Cancer.

Journal: Molecular therapy. Nucleic acids

Published: August 13, 2019

Up-regulated long non-coding RNA DUXAP8 promotes cell growth through repressing Krüppel-like factor 2 expression in human hepatocellular carcinoma.

Up-regulated long non-coding RNA DUXAP8 promotes cell growth through repressing Krüppel-like factor 2 expression in human hepatocellular carcinoma.

Journal: OncoTargets and therapy

Published: May 03, 2019

Identification of differential expressed lncRNAs in human thyroid cancer by a genome-wide analyses.

Identification of differential expressed lncRNAs in human thyroid cancer by a genome-wide analyses.

Journal: Cancer medicine

Published: April 21, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026